
Role of CROs in advancing Immuno oncology
Abstract: Immuno-oncology is a promising field of cancer research that aims to harness the immune system to fight cancer. Contract research organizations (CROs) play a
![]()

Abstract: Immuno-oncology is a promising field of cancer research that aims to harness the immune system to fight cancer. Contract research organizations (CROs) play a
![]()

This blog tackles all the questions regarding ethical procurement of biological samples, various specimen types/formats and intended research use of each format. Abstract: If you
![]()

Abstract: If you have ever wondered what happens to your blood, tissue, or other biological samples after you donate them for research, this blog post
![]()


Cureline Baltic COO Agne Vaitkeviciene has presented Cureline Group – Global Translational CRO activies in preclinical and translational research at Bioplus Interphaex Korea 2022. Thank you Lithuanian Biotechnology Association Innovation Agency Lithuania and
![]()

Brisbane, CA — September 27, 2022 It has been an exciting journey for the Cureline Group, from the time CEO Dr. Olga Potapova spearheaded the
![]()

THE CURELINE GROUP and CELLECTA, Inc Partner to Launch Tissue 2 Target™ Services Partnering human biospecimen management excellence with proven molecular analysis
![]()

Abstract: Artificial intelligence (AI) and digital pathology are two rapidly developing fields that have the potential to revolutionize healthcare. AI can be used to automate
![]()

This blog tackles all the questions regarding ethical procurement of biological samples, various specimen types/formats and intended research use of each format. Abstract: If you
![]()

The Cureline Group, and palleos healthcare, today announced a strategic partnership to offer end-to-end solutions for medical innovation. “This partnership will leverage both companies’ complementary
![]()